From defense to disease: IFITM3 in immunity and Alzheimer's disease Review


Authors: Kehs, Z.; Cross, A. C.; Li, Y. M.
Review Title: From defense to disease: IFITM3 in immunity and Alzheimer's disease
Abstract: Innate immunity protein interferon induced transmembrane protein 3 (IFITM3) is a transmembrane protein that has a wide array of functions, including in viral infections, Alzheimer's Disease (AD), and cancer. As an interferon stimulated gene (ISG), IFITM3's expression is upregulated by type-I, II, and III interferons. Moreover, the antiviral activity of IFITM3 is modulated by post-translational modifications. IFITM3 functions in innate immunity to disrupt viral fusion and entry to the plasma membrane as well as prevent viral escape from endosomes. As a γ-secretase modulatory protein, IFITM3 distinctly modulates the processing of amyloid precursor protein (APP) to generate amyloid beta peptides (Aβ) and Notch1 cleavages. Increased IFITM3 expression, which can result from aging, cytokine activation, inflammation, and infection, can lead to an upregulation of γ-secretase for Aβ production that causes a risk of AD. Therefore, the prevention of IFITM3 upregulation has potential in the development of novel therapies for the treatment of AD. © 2024 The Author(s)
Keywords: review; infection; inflammation; protein processing; cell membrane; innate immunity; aging; upregulation; immunity; alzheimer disease; antiviral activity; amyloid precursor protein; gamma secretase; endosome; etiology; amyloid; amyloid beta protein; γ-secretase; human; neuroimmunology
Journal Title: Neurotherapeutics
Volume: 22
Issue: 3
ISSN: 1933-7213
Publisher: The American Society for Experimental Neurotherapeutics, Inc  
Date Published: 2025-04-01
Start Page: e00482
Language: English
DOI: 10.1016/j.neurot.2024.e00482
PUBMED: 39516072
PROVIDER: scopus
PMCID: PMC12047391
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors is MSK author: Yue-Ming Li -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yueming Li
    132 Li
  2. Zoe Ann Kehs
    2 Kehs
  3. Abigail Christine Cross
    1 Cross